A European collaborative study of cyclophosphamide, bortezomib, and dexamethasone in upfront treatment of systemic AL amyloidosis.
Phase of Trial: Phase IV
Latest Information Update: 18 Nov 2015
At a glance
- Drugs Bortezomib (Primary) ; Cyclophosphamide (Primary) ; Dexamethasone (Primary)
- Indications Amyloid light-chain amyloidosis
- Focus Therapeutic Use
- 18 Nov 2015 New trial record